A detailed history of Nikko Asset Management Americas, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Nikko Asset Management Americas, Inc. holds 678,468 shares of EXAS stock, worth $40.3 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
678,468
Previous 721,088 5.91%
Holding current value
$40.3 Million
Previous $30.5 Million 51.64%
% of portfolio
0.53%
Previous 0.36%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$42.43 - $70.83 $1.81 Million - $3.02 Million
-42,620 Reduced 5.91%
678,468 $46.2 Million
Q2 2024

Aug 09, 2024

SELL
$41.33 - $74.26 $33.3 Million - $59.9 Million
-806,838 Reduced 52.81%
721,088 $30.5 Million
Q1 2024

May 02, 2024

SELL
$56.27 - $73.77 $13 Million - $17 Million
-230,927 Reduced 13.13%
1,527,926 $106 Million
Q4 2023

Feb 08, 2024

SELL
$59.06 - $75.72 $12.1 Million - $15.5 Million
-204,394 Reduced 10.41%
1,758,853 $130 Million
Q3 2023

Nov 09, 2023

SELL
$65.94 - $99.04 $14.4 Million - $21.7 Million
-218,843 Reduced 10.03%
1,963,247 $134 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $69.1 Million - $105 Million
-1,101,885 Reduced 33.55%
2,182,090 $205 Million
Q1 2023

May 03, 2023

SELL
$47.19 - $70.77 $75.1 Million - $113 Million
-1,591,434 Reduced 32.64%
3,283,975 $223 Million
Q4 2022

Feb 13, 2023

SELL
$30.35 - $53.15 $35 Million - $61.3 Million
-1,153,211 Reduced 19.13%
4,875,409 $241 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $22.6 Million - $35 Million
708,216 Added 13.31%
6,028,620 $197 Million
Q2 2022

Aug 04, 2022

BUY
$35.61 - $76.23 $5.55 Million - $11.9 Million
155,939 Added 3.02%
5,320,404 $200 Million
Q1 2022

May 06, 2022

SELL
$57.56 - $82.54 $14.6 Million - $21 Million
-254,335 Reduced 4.69%
5,164,465 $361 Million
Q4 2021

Feb 08, 2022

BUY
$72.5 - $100.68 $88.3 Million - $123 Million
1,218,384 Added 29.01%
5,418,800 $413 Million
Q3 2021

Nov 09, 2021

BUY
$90.24 - $124.05 $86.3 Million - $119 Million
955,854 Added 29.46%
4,200,416 $382 Million
Q2 2021

Aug 09, 2021

BUY
$93.66 - $139.27 $98 Million - $146 Million
1,046,432 Added 47.61%
3,244,562 $402 Million
Q1 2021

May 03, 2021

BUY
$116.57 - $155.01 $102 Million - $135 Million
872,841 Added 65.86%
2,198,130 $290 Million
Q4 2020

Feb 11, 2021

BUY
$99.61 - $142.12 $120 Million - $172 Million
1,209,150 Added 1041.12%
1,325,289 $176 Million
Q3 2020

Nov 02, 2020

BUY
$72.92 - $102.01 $8.47 Million - $11.8 Million
116,139 New
116,139 $11.9 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Nikko Asset Management Americas, Inc. Portfolio

Follow Nikko Asset Management Americas, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikko Asset Management Americas, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikko Asset Management Americas, Inc. with notifications on news.